Rapid Micro Biosystems, Inc. (RPID) stock
RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3057% below fair value
$0.65−0.02 (-2.98%)
Close on Nov 13, 2026Market cap $32.65MP/E –Yield –
Rapid Micro Biosystems total assets
Total assets on the balance sheet at the end of each period.
Rapid Micro Biosystems's total assets was $58.45M at Jun 30, 2026. For fiscal 2025 it was $74.85M, down 23.8% from the year before. The highest annual figure on record is $241.17M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $74.85M | -23.8% |
| FY2024 | Dec 31, 2024 | $98.17M | -31.6% |
| FY2023 | Dec 31, 2023 | $143.45M | -24.8% |
| FY2022 | Dec 31, 2022 | $190.65M | -20.9% |
| FY2021 | Dec 31, 2021 | $241.17M | +244.5% |
| FY2020 | Dec 31, 2020 | $70.00M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $58.45M | -22.7% |
| Q1 FY2026 | Mar 31, 2026 | $62.36M | -27.0% |
| Q4 FY2025 | Dec 31, 2025 | $74.85M | -23.8% |
| Q3 FY2025 | Sep 30, 2025 | $84.41M | -20.3% |
| Q2 FY2025 | Jun 30, 2025 | $75.59M | -35.4% |
| Q1 FY2025 | Mar 31, 2025 | $85.43M | -33.1% |
| Q4 FY2024 | Dec 31, 2024 | $98.17M | -31.6% |
| Q3 FY2024 | Sep 30, 2024 | $105.84M | -29.5% |
| Q2 FY2024 | Jun 30, 2024 | $117.09M | -27.3% |
| Q1 FY2024 | Mar 31, 2024 | $127.73M | -26.3% |
| Q4 FY2023 | Dec 31, 2023 | $143.45M | -24.8% |
| Q3 FY2023 | Sep 30, 2023 | $150.16M | -25.6% |
| Q2 FY2023 | Jun 30, 2023 | $160.95M | -25.5% |
| Q1 FY2023 | Mar 31, 2023 | $173.28M | -24.7% |
| Q4 FY2022 | Dec 31, 2022 | $190.65M | -20.9% |
| Q3 FY2022 | Sep 30, 2022 | $201.92M | -20.6% |
| Q2 FY2022 | Jun 30, 2022 | $216.14M | +67.2% |
| Q1 FY2022 | Mar 31, 2022 | $230.05M | +228.7% |
| Q4 FY2021 | Dec 31, 2021 | $241.17M | – |
| Q3 FY2021 | Sep 30, 2021 | $254.43M | – |
| Q2 FY2021 | Jun 30, 2021 | $129.24M | – |
| Q4 FY2020 | Dec 31, 2020 | $70.00M | – |
See a number that looks wrong?